Ben Liu

AI will transform biopharma unevenly, with some areas of drug discovery and development already seeing impact, according to an article by Ben Liu. The sequence of change matters as different sectors a…

AI will transform biopharma unevenly, with drug discovery becoming abundant while clinical development remains the binding constraint. Companies that build durable positions around the development bot…